Drug utilization and therapy provision patterns by prescriber types among patients with systemic lupus erythematosus in Korea.

about

Drug utilization and therapy provision patterns by prescriber types among patients with systemic lupus erythematosus in Korea.

Item

http://www.wikidata.org/entity/Q47143263

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Drug utilization and therapy p ...... lupus erythematosus in Korea.

@en

Drug utilization and therapy p ...... lupus erythematosus in Korea.

@nl

type

Item

label

Drug utilization and therapy p ...... lupus erythematosus in Korea.

@en

Drug utilization and therapy p ...... lupus erythematosus in Korea.

@nl

prefLabel

Drug utilization and therapy p ...... lupus erythematosus in Korea.

@en

Drug utilization and therapy p ...... lupus erythematosus in Korea.

@nl

P1476

Drug utilization and therapy p ...... lupus erythematosus in Korea.

@en

P2093

Sooyoung Shin

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Multi-indication carbamazepine and the risk of severe cutaneous adverse drug reactions in Korean elderly patients: a Korean health insurance data-based study

Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data.

Factors associated with low bone mineral density in female patients with systemic lupus erythematosus.

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.

Severe major organ involvement in systemic lupus erythematosus. Diagnosis and management.

Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.

Understanding the epidemiology and progression of systemic lupus erythematosus

Antimalarials--the 'real' advance in lupus.

Current and novel therapeutics in the treatment of systemic lupus erythematosus

P304

1779-1787

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/PPA.S146119

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29081653

http://www.w3.org/2001/XMLSchema#string

P932

5652906

http://www.w3.org/2001/XMLSchema#string